Association of controlled attenuation parameter (CAP) and HbA1c in patients with fatty liver

Background and aim: Chronic liver diseases and serum glycosylated hemoglobin (HbA1c) levels are linked to one another through the metabolic syndrome. Our aim was to analyze for the first time the potential association between hepatic steatosis, using the controlled attenuation parameter (CAP), and HbA1c. Patients and methods: At a tertiary referral center in Deutschland, we evaluated 212 outpatients. Steatosis was assessed non-invasively using CAP, which quantifies the degree of ultrasound attenuation based on transient elastography (Fibroscan). Serum HbA1c and liver function tests were measured with standardize…